Finance

Lists
TELA:NASDAQ
TELA Bio Inc
$0.64
-1.08%
(-0.0070) 1D
Aug 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TELA...
Open
$0.65
High
$0.69
Low
$0.62
Mkt. cap
28.87M
Avg. vol.
124.39K
Volume
297.02K
52-wk high
$2.00
52-wk low
$0.50
EPS
-$0.77
Beta
1.34
Shares outstanding
44.90M
No. of employees
218
Open
$0.65
High
$0.69
Low
$0.62
Mkt. cap
28.87M
Avg. vol.
124.39K
Volume
297.02K
52-wk high
$2.00
52-wk low
$0.50
EPS
-$0.77
Beta
1.34
Shares outstanding
44.90M
No. of employees
218
News stories
From web sources and news partners
About TELA Bio Inc
CEO-
Employees218
Founded2012
HeadquartersMalvern, Pennsylvania, United States
SectorMedical device
Analyst ratings
Based on 3 analysts giving stock ratings to TELA in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for TELA in the last 3 months.
Highest
Current $0.64
$2.00 (+211.04%)
Average
$1.67 (+159.72%)
Lowest
$1.00 (+55.52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Caitlin Roberts
Canaccord Genuity
Buy
Maintained
$2.00
+211%
08/17/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$2.00
+211%
08/11/2026
Matthew O'Brien
Piper Sandler
Hold
Maintained
$1.00
+55.5%
08/11/2026
David Turkaly
Citizens JMP
Buy
Maintained
$3.00
+366.6%
03/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
20.69M
20.87M
19.06M
19.29M
Cost of goods sold
6.62M
7.02M
6.44M
5.25M
Cost of revenue
6.62M
7.02M
6.44M
5.25M
Research and development expenses
2.35M
2.13M
2.34M
2.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.18M
18.27M
20.70M
20.50M
Operating expense
21.62M
20.50M
23.14M
23.32M
Total operating expenses
28.24M
27.52M
29.58M
28.57M
Operating income
-7.55M
-6.65M
-10.53M
-9.28M
Other non operating income
152.00K
277.00K
366.00K
157.00K
EBT including unusual items
-8.60M
-8.90M
-12.21M
-11.20M
EBT excluding unusual items
-8.60M
-8.01M
-12.21M
-11.20M
Income tax expense
-
145.00K
60.00K
60.00K
Effective tax rate
-
-1.63%
-0.49%
-0.54%
Other operating expenses
-
-
-
-
Net income
-8.60M
-9.04M
-12.27M
-11.26M
Net profit margin
-41.58%
-43.32%
-64.39%
-58.38%
Earnings per share
-0.19
-0.17
-0.21
-0.20
Interest and investment income
-
-
-
-
Interest expense
-1.20M
-1.64M
-2.05M
-2.08M
Net interest expenses
-1.20M
-1.64M
-2.05M
-2.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.31M
-6.42M
-10.26M
-9.02M
Gain or loss from assets sale
-
-
18.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps